Skip to main content Accessibility help
×
Home
  • Print publication year: 2011
  • Online publication date: March 2012

Chapter 62 - Glioma

from Section 3 - Symptomatic epilepsy

References

Alger JR, Frank JA, Bizzi A, et al. (1990) Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology 177:633–41.
Aronica E, Gorter JA, Jansen GH, et al. (2001) Expression of connexin 43 and connexin 32 gap-junction proteins in epilepsy-associated brain tumors and in the perilesional epileptic cortex. Acta Neuropathol 101:449–59.
Aronica E, Yankaya B, Jansen GH, et al. (2001) Ionotropic and metabotropic glutamate receptor protein expression in glioneuronal tumors from patients with intractable epilepsy. Neuropathol Appl Neurobiol 27:223–37.
Asano E, Juhasz C, Shah A, et al. (2009). Role of subdural electrocorticography in prediction of long-term seizure outcome in epilepsy surgery. Brain 132:1038–47.
Benitez JA, Arregui L, Cabreva G, et al. (2008) Valproic acid induces polarization, neuronal-like differentiation of a subpopulation of C6 glioma cells and selectively regulates transgene expression. Neuroscience 156:911–20.
Berger MS, Ghatan S, Haglund MM, et al. (1993) Low-grade gliomas associated with intractable epilepsy: seizure outcome utilizing electrocorticography during tumor resection. J Neurosurg 79:62–9.
Boon PA, Williamson PD, Fried I, et al. (1991) Intracranial, intraaxial, space-occupying lesions in patients with intractable partial seizures: an anatomoclinical, neuropsychological, and surgical correlation. Epilepsia 32:467–76.
Brada M, Viviers L, Abson C, et al. (2003) Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol 14:1715–21.
Cairncross JG, Laperriere NJ (1989) Low-grade glioma: to treat or not to treat?” Arch Neurol 46:1238–9.
Cascino GD, Kelly PJ, Hirschhorn KA, et al. (1992) Long-term follow-up of stereotactic lesionectomy in partial epilepsy: predictive factors and electroencephalographic results. Epilepsia 33:639–44.
CBTRUS (2007) Statistical Report: Primary Brain Tumors in the United States. Hinsdale, IL: Central Brain Tumor Registry of the United States.
Chandana SR, Movva S, Aora M, et al. (2008) Primary brain tumors in adults. Am Fam Physician 77:1423–30.
Chang EF, Potts MB, Keles GE, et al. (2008) Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg 108:227–35.
Claus EB, Horlacher A, Hsu L, et al. (2005) Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance. Cancer 103:1227–33.
Ding L, Wilke C, Xu B, et al. (2007) EEG source imaging: correlating source locations and extents with electrocorticography and surgical resections in epilepsy patients. J Clin Neurophysiol 24:130–6.
Engelhard HH, Stelea A, Cochran EJ, (2002) Oligodendroglioma: pathology and molecular biology. Surg Neurol 58:111–17; discussion 117.
Fischgold HZ, Buisson B, Ferey J (1961) Electroencephalography and cerebral tumors: general comments on the use of EEG in the diagnosis and localization of cerebral tumors. EEG Clin Neurophysiol 19(Suppl):51–74.
Fried I, Kim JH, Spencer DD (1992) Hippocampal pathology in patients with intractable seizures and temporal lobe masses. J Neurosurg 76:735–40.
Fried I, Kim JH, Spencer DD (1994) Limbic and neocortical gliomas associated with intractable seizures: a distinct clinicopathological group. Neurosurgery 34:815–23; discussion 823–4.
Gerstle de Paquet EPM, Iniquez RA (1976) Epileptic seizures as an early complication of neurosurgery. Acta Neurol Latinoamericana 22:144–51.
Goldring S, Rich KM, Picker S (1986) Experience with gliomas in patients presenting with a chronic seizure disorder. Clin Neurosurg 33:15–42.
Haglund MB, Shamseldin M, Lettich E, Ojemann GA (1992) Changes in gamma-aminobutyric acid and somatostatin in epileptic cortex associated with low-grade gliomas. J Neurosurg 77:209–16.
Hart MG, Garside R, Rogers G, Somerville M, Stein K (2008a). Chemotherapeutic wafers for high grade glioma. Cochrane Database Syst Rev 3:CD007294.
Hart MG, Garside R, Rogers G, Somerville M, Stein K (2008b). Temozolomide for high grade glioma. Cochrane Database Syst Rev 4:CD007415.
Hauser WA, Annegers JF, Kurland LT (1993) Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935–1984. Epilepsia 34:453–68.
Hirsch JB-F, Sachs M, Hirsch JC, Scherrer J (1966) Electrocorticogramme et activités unitaires lors de processus expansifs chez l'homme. EEG Clin Neurophysiol 21:417–28.
Hoh BL, Chapman PH, Loeffler JS, et al. (2002) Results of multimodality treatment for 141 patients with brain arteriovenous malformations and seizures: factors associated with seizure incidence and seizure outcomes. Neurosurgery 51:303–9; discussion 309–11.
Idbaih A, Omuro A, Ducray F, Hoang-Xuan K (2007) Molecular genetic markers as predictors of response to chemotherapy in gliomas. Curr Opin Oncol 19:606–11.
Ivens S, Kaufer D, Flores LP, et al. (2007). TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain 130:535–47.
Iwamoto FM, Nicolardi L, Demopoulos A, et al. (2008) Clinical relevance of 1p and 19q deletion for patients with WHO grade 2 and 3 gliomas. J Neurooncol 88:293–8.
Kaloshi G, Benouaich-Amiel A, Daikite F, et al. (2007) Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology 68:1831–6.
Keles GE, Lamborn KR, Berger S (2001) Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J Neurosurg 95:735–45.
Levesque MN, Vinters HV, Babb TL (1991) Surgical treatment of limbic epilepsy associated with extrahippocampal lesions: the problem of dual pathology. J Neurosurg 75:364–70.
Li L, Cendes F, Watson C, et al. (1997) Surgical treatment of patients with single and dual pathology. Neurology 48:437–44.
Li L, Cendes F, Andermann F, et al. (1999) Surgical outcome in patients with epilepsy and dual pathology. Brain 122:799–805.
Loscher W, Potschka H (2002) Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. J Pharmacol Exp Ther 301:7–14.
Lote K, Stenwig AE, Skullerud K, Hirschberg H (1998) Prevalence and prognostic significance of epilepsy in patients with gliomas. Eur J Cancer 34:98–102.
Louis DN, Ohgaki H, Wiestler OD, et al. (2007) The 2007 WHO classification of tumors of the central nervous system. Acta Neuropathol 114:97–109.
Luyken C, Blümcke I, Fimmers R, et al. (2003) The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects. Epilepsia 44:822–30.
Lyons SA, Chung WJ, Weaver AK, et al. (2007) Autocrine glutamate signaling promotes glioma cell invasion. Cancer Res 67:9463–71.
Mandonnet E, Delattre JY, Tanguy ML, et al. (2003) Continuous growth of mean tumor diameter in a subset of grade II gliomas. Ann Neurol 53:524–8.
Maschio M, Dinapoli L, Zarabla A, Jandolo B (2006) Issues related to the pharmacological management of patients with brain tumors and epilepsy. Funct Neurol 21:15–19.
Newman EA (2003) New roles for astrocytes: regulation of synaptic transmission. Trends Neurosci 26:536–42.
Oberndorfer S, Piribauer M, Marosi C, et al. (2005) P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy. J Neurooncol 72:255–60.
Ohgaki H (2009) Epidemiology of brain tumors. Methods Mol Biol 472:323–42.
Ohgaki H, Dessen P, Jourde B, et al. (2004) Genetic pathways to glioblastoma: a population-based study. Cancer Res 64:6892–9.
Peiffer J, Kleihues P (1999) Hans-Joachim Scherer (1906–1945), pioneer in glioma research. Brain Pathol 9:241–5.
Piepmeier J, Fried I, Makuch P (1993) Low-grade astrocytomas may arise from different astrocyte lineages. Neurosurgery 33:627–32.
Piepmeier J, Christopher S, Spencer D, et al. (1996) Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas. Neurosurgery 38:872–8; discussion 878–9.
Pouratian N, Asthagiri A, Jagannathan J, et al. (2007) Surgery insight: the role of surgery in the management of low-grade gliomas. Nat Clin Pract Neurol 3:628–39.
Price SJ (2007) The role of advanced MR imaging in understanding brain tumor pathology. Br J Neurosurg 21:562–75.
Rajneesh KF, Binder DK (2009) Tumor-associated epilepsy. Neurosurg Focus 27:E4.
Recht LD, Lew R, Smith TW (1992) Suspected low-grade glioma: is deferring treatment safe? Ann Neurol 31:431–6.
Roessler K, Suchanek G, Breitschopf H, et al. (1995) Detection of tumor necrosis factor-alpha protein and messenger RNA in human glial brain tumors: comparison of immunohistochemistry with in situ hybridization using molecular probes. J Neurosurg 83:291–7.
Rogers LR, Morris HH, Lupica K (1993) Effect of cranial irradiation on seizure frequency in adults with low-grade astrocytoma and medically intractable epilepsy. Neurology 43:1599–601.
Sakatani S, Seto-Ohshima A, Shinohara Y, et al. (2008) Neural-activity-dependent release of S100B from astrocytes enhances kainate-induced gamma oscillations in vivo. J Neurosci 28:10 928–36.
Sander JW, Johnson AL, Shorvon SD (1990) National General Practice Study of Epilepsy: newly diagnosed epileptic seizures in a general population. Lancet 336:1267–71.
Schaller B (2005) Influences of brain tumor-associated pH changes and hypoxia on epileptogenesis. Acta Neurol Scand 111:75–83.
Schaller B, Ruegg SJ (2003) Brain tumor and seizures: pathophysiology and its implications for treatment revisited. Epilepsia 44:1223–32.
Schrottner O, Unger F, Eder HG, et al. (2002) Gamma-knife radiosurgery of mesiotemporal tumor epilepsy observations and long-term results. Acta Neurochir 84 (Suppl):49–55.
Schwartz TH, Bazil CW, Forgione M, et al. (2000) Do reactive post-resection “injury” spikes exist? Epilepsia 41:1463–8.
Semyanov A, Walker MC, Kullman DM (2003) GABA uptake regulates cortical excitability via cell type-specific tonic inhibition. Nat Neurosci 6:484–90.
Sirven JI, Wingerchuk DM, Drazkowski JF, et al. (2004) Seizure prophylaxis in patients with brain tumors: a meta-analysis. Mayo Clin Proc 79:1489–94.
Spencer DD, Spencer SS, Mattson RH, Williamson PD (1984) Intracerebral masses in patients with intractable partial epilepsy. Neurology 34:432–6.
Stellwagen D, Malenka RC (2006) Synaptic scaling mediated by glial TNF-alpha. Nature 440:1054–9.
Stewart L, Burdett S, Glioma Meta-Analysis Trialists Group (2002). Chemotherapy for high-grade glioma. Cochrane Database Syst Rev 3:CD003913.
Tanaka K, Watase K, Manabe T, et al. (1997) Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276:1699–702.
Tremont-Lukats IW, Ratilal BO, Armstrong T, et al. (2008) Antiepileptic drugs for preventing seizures in people with brain tumors. Cochrane Database Syst Rev(2):CD004424.
van Breemen MS, Wilms EB, Vecht CJ, et al. (2007) Epilepsy in patients with brain tumors: epidemiology, mechanisms, and management. Lancet Neurol 6:421–30.
van den Bent MJ, de Witte O, Ben Hassel M, et al. (2005). Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 366:985–90.
Vezzani A, Ravizza T, Balosso S, et al. (2008) Glia as a source of cytokines: implications for neuronal excitability and survival.” Epilepsia 49(Suppl 2):24–32.
Vojtech Z, Vladyka V, Kalina M, et al. (2009) The use of radiosurgery for the treatment of mesial temporal lobe epilepsy and long-term results. Epilepsia 50:2061–71.
Wolf HK, Roos D, Blümcke I, et al. (1996) Perilesional neurochemical changes in focal epilepsies. Acta Neuropathol 91:376–84.
Wong M (2008) Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation. Epilepsia 49:8–21.
Yap KY, Chui WK, Chan A (2008) Drug interactions between chemotherapeutic regimens and antiepileptics. Clin Ther 30:1385–407.